Adcendo

Developer of antibody-drug conjugates for the treatment of cancer

placeFrederiksberg, Capital Region Of Denmark, Denmark calendar_todayFounded 2017 groups23 employees language adcendo.com

Registered entities

Social engagement

Social engagement: 10.8K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

20 investors on record; lead investors include Gilde Healthcare, RA Capital Management, Ysios Capital, Healthcap.

Investor typeCountShare
Venture capital945%
Private equity315%
Accelerator & incubator15%
Bank & private debt210%
Other / undisclosed525%
Coming soon